CytoAgents Newsroom

The Pittsburgh Technology Council celebrated the 25th annual Tech 50 Awards on Nov. 10, 2021 to honor the fastest growing and most innovative technology companies, service providers and CEOS in the Pittsburgh region.

PITTSBURGH–(BUSINESS WIRE)–CytoAgents, Inc., a clinical-stage biotechnology company developing a safe, effective treatment for Cytokine Release Syndrome (CRS), today announced that it has received a Study May Proceed letter from the U.S. Food and Drug Administration…

Ernst & Young LLP (EY US) today announced that Teresa Whalen, RPh, CEO of CytoAgents, was named an Entrepreneur Of The Year® 2023 East Central Award finalist.

As Teresa Whalen says in her “Our Region’s Business” interview hosted by Bill Flanagan on WPXI-TV, “2023 will be a breakout year for CytoAgents.”

Press Releases
View all of the latest news and announcements from CytoAgents
Media coverage
Read what the media has to say about CytoAgents
Learn about past and upcoming events for CytoAgents

Interested in Learning More about CytoAgents?

Contact us